SAREPTA THERAPEUTICS, INC. Earnings Per Share (Diluted)
SAREPTA THERAPEUTICS, INC. (SRPT) reported Earnings Per Share (Diluted) of -$0.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.05, a 102.65% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was $2.88.
- SAREPTA THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$3.93, a 362.00% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.50, a 247.06% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. earnings per share, diluted for fiscal 2025 was -$7.13, a 404.70% decline from fiscal 2024.
- SAREPTA THERAPEUTICS, INC. earnings per share, diluted for fiscal 2024 was $2.34.
- SAREPTA THERAPEUTICS, INC. earnings per share, diluted for fiscal 2023 was -$5.80.
- SAREPTA THERAPEUTICS, INC. earnings per share, diluted for fiscal 2022 was -$8.03.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.05 10-Q · filed 2026-08-05 | $2.99 10-Q · filed 2026-08-05 | $0.57 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||
| 2026-03-31 | $2.88 10-Q · filed 2026-05-06 | $0.60 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-05-06 | $0.82 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||
| 2025-12-31 | -$3.93 10-K · filed 2026-03-02 | -$4.51 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$2.52 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$7.13 10-K · filed 2026-03-02 | ||
| 2025-09-30 | -$0.50 10-K · filed 2026-03-02 | -$1.80 10-Q · filed 2025-11-06 | $0.21 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$4.37 10-Q · filed 2025-11-06 | -$2.30 derived: net income ÷ weighted average shares · filed 2026-08-05 | |
| 2025-06-30 | $1.89 10-Q · filed 2026-08-05 | -$2.57 10-Q · filed 2026-08-05 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||
| 2025-03-31 | -$4.60 10-Q · filed 2026-05-06 | -$2.37 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$2.17 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$2.16 derived: net income ÷ weighted average shares · filed 2026-05-06 | ||
| 2024-12-31 | $1.50 10-K · filed 2026-03-02 | $1.79 derived: net income ÷ weighted average shares · filed 2026-03-02 | $1.95 derived: net income ÷ weighted average shares · filed 2026-03-02 | $2.34 10-K · filed 2026-03-02 | ||
| 2024-09-30 | $0.34 10-K · filed 2026-03-02 | $0.41 derived: net income ÷ weighted average shares · filed 2025-11-06 | $0.78 10-Q · filed 2025-11-06 | $1.22 derived: net income ÷ weighted average shares · filed 2026-03-02 | ||
| 2024-06-30 | $0.07 10-K · filed 2026-03-02 | $0.44 10-Q · filed 2025-08-06 | $0.88 derived: net income ÷ weighted average shares · filed 2026-03-02 | $0.49 derived: net income ÷ weighted average shares · filed 2026-03-02 | ||
| 2024-03-31 | $0.37 10-K · filed 2026-03-02 | $0.81 derived: net income ÷ weighted average shares · filed 2026-03-02 | $0.42 derived: net income ÷ weighted average shares · filed 2026-03-02 | |||
| 2023-12-31 | $0.44 derived: net income ÷ weighted average shares · filed 2026-03-02 | $0.05 derived: net income ÷ weighted average shares · filed 2026-03-02 | -$5.80 10-K · filed 2026-03-02 | |||
| 2023-09-30 | -$0.46 10-Q · filed 2024-11-06 | -$6.56 10-Q · filed 2024-11-06 | ||||
| 2023-06-30 | -$0.27 10-Q · filed 2024-08-07 | -$6.11 10-Q · filed 2024-08-07 | ||||
| 2023-03-31 | -$5.86 10-Q · filed 2024-05-01 | |||||
| 2022-12-31 | -$8.03 10-K · filed 2025-02-28 | |||||
| 2022-09-30 | -$2.94 10-Q · filed 2023-11-01 | -$6.79 10-Q · filed 2023-11-01 | ||||
| 2022-06-30 | -$2.65 10-Q · filed 2023-08-02 | -$3.85 10-Q · filed 2023-08-02 | ||||
| 2022-03-31 | -$1.20 10-Q · filed 2023-05-02 | |||||
| 2021-12-31 | -$5.15 10-K · filed 2024-02-28 | |||||
| 2021-09-30 | -$0.60 10-Q · filed 2022-11-02 | -$3.72 10-Q · filed 2022-11-02 | ||||
| 2021-06-30 | -$1.02 10-Q · filed 2022-08-02 | -$3.12 10-Q · filed 2022-08-02 | ||||
| 2020-12-31 | -$7.11 10-K · filed 2023-02-28 | |||||
| 2018-06-30 | -$1.67 10-Q · filed 2018-08-08 | -$2.22 10-Q · filed 2018-08-08 | ||||
| 2018-03-31 | -$0.55 10-Q · filed 2018-05-03 | |||||
| 2017-12-31 | -$0.37 10-K · filed 2019-02-28 | |||||
| 2017-09-30 | -$0.78 10-K · filed 2019-02-28 | |||||
| 2017-06-30 | -$1.15 10-K · filed 2019-02-28 | $0.37 10-Q · filed 2018-08-08 | ||||
| 2017-03-31 | $1.50 10-K · filed 2019-02-28 | |||||
| 2016-06-30 | -$1.35 10-Q · filed 2017-08-03 | -$2.66 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | -$1.31 10-Q · filed 2017-05-04 | |||||
| 2013-09-30 | -$1.24 10-Q · filed 2013-11-12 | -$3.17 10-Q · filed 2013-11-12 | ||||
| 2013-06-30 | -$0.60 10-Q · filed 2013-08-08 | -$1.92 10-Q · filed 2013-08-08 | ||||
| 2012-12-31 | -$2.36 10-K · filed 2014-03-03 | |||||
| 2012-09-30 | -$2.17 10-K · filed 2014-03-03 | -$2.61 10-Q · filed 2013-11-12 | ||||
| 2012-06-30 | $0.35 10-K · filed 2014-03-03 | -$0.43 10-Q · filed 2013-08-08 | ||||
| 2012-03-31 | -$0.78 10-K · filed 2014-03-03 | -$0.13 10-Q · filed 2012-05-10 | ||||
| 2011-12-31 | -$0.06 10-K · filed 2013-03-15 | -$0.02 10-K · filed 2012-03-13 | ||||
| 2011-09-30 | -$0.18 10-K · filed 2013-03-15 | -$0.04 10-Q · filed 2012-11-07 | ||||
| 2011-06-30 | $0.06 10-K · filed 2013-03-15 | $0.01 10-Q · filed 2011-08-08 | $0.14 10-Q · filed 2012-08-07 | $0.02 10-Q · filed 2011-08-08 | ||
| 2011-03-31 | $0.09 10-K · filed 2013-03-15 | $0.02 10-Q · filed 2012-05-10 | ||||
| 2010-12-31 | -$0.29 10-K · filed 2012-03-13 | |||||
| 2010-06-30 | -$0.15 10-Q · filed 2011-08-08 | -$0.16 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | -$0.27 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |